<DOC>
	<DOCNO>NCT01265147</DOCNO>
	<brief_summary>This phase II trial study cisplatin nedaplatin combine IMRT evaluate one good efficacy security nasopharyngeal carcinoma .</brief_summary>
	<brief_title>Intensity-modulated Radiation Therapy Combined With Cisplatin Nedaplatin Chemotherapy Nasopharyngeal Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Age≥18 , T12aN13 ; T24NxNPC , VEGFR+ , ++ , KPS＞70 , Life expectancy≥6 month , No uncontrolled hypertension , cardiac failure , diabetes , lunacy Distant metastasis , recurrent disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>